TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$3.16M2013: -$6.77M2015: -$17.10M2016: -$16.22M2017: -$7.22M2018: -$6.92M2019: -$15.11M2020: -$60.84M2021: -$125.70M2022: -$161.25M2023: -$103.70M2024: -$83.89M2025: -$59.10M-$59.10M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$59.10M+29.6%
2024-$83.89M+19.1%
2023-$103.70M+35.7%
2022-$161.25M-28.3%
2021-$125.70M-106.6%
2020-$60.84M-302.7%
2019-$15.11M-118.4%
2018-$6.92M+4.2%
2017-$7.22M+55.5%
2016-$16.22M+5.2%
2015-$17.10M—
2013-$6.77M-114.6%
2012-$3.16M—